| Literature DB >> 25890975 |
Vittoria Locato1, Esther Novo Uzal2, Sara Cimini1, Maria Chiara Zonno3, Antonio Evidente4, Alessandra Micera5, Christine H Foyer6, Laura De Gara7.
Abstract
Ophiobolin A, a tetracyclic sesterpenoid produced by phytopathogenic fungi, is responsible for catastrophic losses in crop yield but its mechanism of action is not understood. The effects of ophiobolin A were therefore investigated on the growth and redox metabolism of Tobacco Bright Yellow-2 (TBY-2) cell cultures by applying concentrations of the toxin that did not promote cell death. At concentrations between 2 and 5 μM, ophiobolin A inhibited growth and proliferation of the TBY-2 cells, which remained viable. Microscopic and cytofluorimetric analyses showed that ophiobolin A treatment caused a rapid decrease in mitotic index, with a lower percentage of the cells at G1 and increased numbers of cells at the S/G2 phases. Cell size was not changed following treatment suggesting that the arrest of cell cycle progression was not the result of a block on cell growth. The characteristic glutathione redox state and the localization of glutathione in the nucleus during cell proliferation were not changed by ophiobolin A. However, subsequent decreases in glutathione and the re-distribution of glutathione between the cytoplasm and nuclei after mitosis occurring in control cells, as well as the profile of glutathionylated proteins, were changed in the presence of the toxin. The profile of poly ADP-ribosylated proteins were also modified by ophiobolin A. Taken together, these data provide evidence of the mechanism of ophiobolin A action as a cell cycle inhibitor and further demonstrate the link between nuclear glutathione and the cell cycle regulation, suggesting that glutathione-dependent redox controls in the nuclei prior to cell division are of pivotal importance.Entities:
Keywords: Cell cycle; Tobacco Bright Yellow-2.; glutathione; glutathionylation; ophiobolin A; poly-ADP-ribosylation
Mesh:
Substances:
Year: 2015 PMID: 25890975 DOI: 10.1093/jxb/erv110
Source DB: PubMed Journal: J Exp Bot ISSN: 0022-0957 Impact factor: 6.992